Cargando…
Prevention of Peripheral Tolerance by a Dendritic Cell Growth Factor: Flt3 Ligand as an Adjuvant
Injections of soluble proteins are poorly immunogenic, and often elicit antigen-specific tolerance. The mechanism of this phenomenon has been an enduring puzzle, but it has been speculated that tolerance induction may be due to antigen presentation by poorly stimulatory, resting B cells, which lack...
Autores principales: | Pulendran, Bali, Smith, J.L., Jenkins, M., Schoenborn, M., Maraskovsky, E., Maliszewski, C.R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212387/ https://www.ncbi.nlm.nih.gov/pubmed/9841921 |
Ejemplares similares
-
Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus
por: Kwissa, Marcin, et al.
Publicado: (2007) -
Flt3 Ligand Regulates Dendritic Cell Development from Flt3(+) Lymphoid and Myeloid-committed Progenitors to Flt3(+) Dendritic Cells In Vivo
por: Karsunky, Holger, et al.
Publicado: (2003) -
Emerging concepts in the science of vaccine adjuvants
por: Pulendran, Bali, et al.
Publicado: (2021) -
Will the Making of Plasmacytoid Dendritic Cells in Vitro Help Unravel Their Mysteries?
por: Banchereau, Jacques, et al.
Publicado: (2000) -
Further Activation of FLT3 Mutants by FLT3 Ligand
por: Zheng, Rui, et al.
Publicado: (2011)